Shares of Agilent Technologies, Inc. (NYSE:A – Get Free Report) have received an average recommendation of “Moderate Buy” from the seventeen research firms that are currently covering the stock, Marketbeat.com reports. Three research analysts have rated the stock with a hold recommendation, thirteen have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is $161.2667.
Several research firms have commented on A. Wall Street Zen raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Saturday, May 30th. Wells Fargo & Company cut their price target on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a report on Thursday, May 28th. Piper Sandler assumed coverage on shares of Agilent Technologies in a research note on Thursday, June 11th. They set a “neutral” rating and a $150.00 price objective for the company. Robert W. Baird raised their target price on Agilent Technologies from $155.00 to $156.00 and gave the stock an “outperform” rating in a report on Tuesday, May 26th. Finally, Royal Bank Of Canada assumed coverage on shares of Agilent Technologies in a research report on Wednesday, May 27th. They issued an “outperform” rating and a $153.00 price objective for the company.
Institutional Trading of Agilent Technologies
Agilent Technologies Price Performance
Agilent Technologies stock opened at $131.42 on Thursday. The stock has a market cap of $37.12 billion, a price-to-earnings ratio of 26.39, a price-to-earnings-growth ratio of 2.25 and a beta of 1.26. The firm has a 50-day moving average of $122.22 and a two-hundred day moving average of $126.32. Agilent Technologies has a 1 year low of $108.35 and a 1 year high of $160.27. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62.
Agilent Technologies (NYSE:A – Get Free Report) last announced its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.41 by $0.08. The firm had revenue of $1.84 billion during the quarter, compared to analyst estimates of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.Agilent Technologies’s quarterly revenue was up 10.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, research analysts forecast that Agilent Technologies will post 6 earnings per share for the current year.
Agilent Technologies Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th will be issued a $0.255 dividend. This represents a $1.02 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 30th. Agilent Technologies’s payout ratio is presently 20.48%.
About Agilent Technologies
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
Featured Stories
- Five stocks we like better than Agilent Technologies
- Why KB Home Could Reward Patient Investors Later
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
- Tesla’s New NHTSA Probe Lands at the Worst Possible Time
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
